Cargando…
Pancreatic adenocarcinoma: Beyond first line, where are we?
Pancreatic cancer is considered one of the most aggressive cancers, with an increasing incidence in recent years. To date, chemotherapy is still the standard of care for advanced metastatic disease, unfortunately providing only a slight advantage in terms of survival. The molecular and cellular char...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108033/ https://www.ncbi.nlm.nih.gov/pubmed/34007126 http://dx.doi.org/10.3748/wjg.v27.i17.1847 |